Clinigen is a healthy trade
It doesn't develop medicines, but Clinigen Group (CLIN:AIM) is making huge profits from the growing demand for pharmaceuticals.The group supplies drugs for clinical trials as well as unlicensed medicines and niche treatments. It...
12 March 2015
